Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 11/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 9/20 | 0.56 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.39 |
| ▸ | PI4KB | Q9UBF8 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzenesulfonamide SCHEMBL7046453 | 0.95 | PTGS2 (0.65) | PTGS2PTGS1ABCB11ALDH1A1 | |
| SCHEMBL8688528 | 0.92 | PTGS2 (0.46) | PTGS2PTGS1ABCB11ALDH1A1 | |
| SCHEMBL8691588 | 0.91 | PTGS2 (0.46) | PTGS2PTGS1ABCB11ALDH1A1SCN9A | |
| SCHEMBL8693376 | 0.89 | PTGS2 (0.57) | PTGS2PTGS1ABCB11ALDH1A1 | |
| SCHEMBL8688815 | 0.89 | PTGS1 (0.46) | PTGS2PTGS1ABCB11ALDH1A1 | |
| SCHEMBL8691532 | 0.88 | PTGS2 (0.55) | PTGS2PTGS1ABCB11ALDH1A1 | |
| Benzenesulfonamide SCHEMBL8163191 | 0.85 | PTGS2 (0.53) | PTGS2PTGS1ABCB11ALDH1A1 | |
| SCHEMBL8688398 | 0.85 | PTGS1 (0.53) | PTGS2PTGS1ABCB11ALDH1A1 | |
| SCHEMBL8640455 | 0.84 | PTGS2 (0.45) | PTGS2PTGS1ABCB11ALDH1A1SCN9A | |
| SCHEMBL8692192 | 0.84 | PTGS2 (0.42) | PTGS2PTGS1ABCB11ALDH1A1SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2001527542-A | — | — | 2001-12-25 | — | — | JP | claimed |
| EP-0979077-A1 | METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE PREVENTION OF CARDIOVASCULAR DISORDERS | G.D. Searle & Co. (US) | 2000-02-16 | — | — | EP | claimed |
| US-5910597-A | Process for preparing 3-haloalkyl-1H-pyrazoles | G.D. SEARLE & CO. (US) | 1999-06-08 | — | — | US | claimed |
| US-5892053-A | Process for preparing 3-haloalkyl-1H-pyrazoles | G. D. SEARLE & CO. (US) | 1999-04-06 | — | — | US | claimed |
| WO-1998047509-A1 | METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE PREVENTION OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1998-10-29 | — | — | WO | claimed |
| US-5760068-A | NONSTEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS | G.D. SEARLE & CO. (US) | 1998-06-02 | — | — | US | claimed |
| US-5700816-A | ANTIARTHRITIC AGENTS | G.D. SEARLE & CO. | 1997-12-23 | — | — | US | claimed |
| US-5910597-A | Process for preparing 3-haloalkyl-1H-pyrazoles | G.D. SEARLE & CO. (US) | 1999-06-08 | — | — | US | disclosed |
| US-5892053-A | Process for preparing 3-haloalkyl-1H-pyrazoles | G. D. SEARLE & CO. (US) | 1999-04-06 | — | — | US | disclosed |
| US-5760068-A | NONSTEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS | G.D. SEARLE & CO. (US) | 1998-06-02 | — | — | US | disclosed |
| US-5756529-A | ANTIINFLAMMATORY | G.D. SEARLE & CO. (US) | 1998-05-26 | — | — | US | disclosed |
| US-5753688-A | ANTIINFLAMMATORY | TALLEY JOHN J (US) | 1998-05-19 | — | — | US | disclosed |
| US-5700816-A | ANTIARTHRITIC AGENTS | G.D. SEARLE & CO. | 1997-12-23 | — | — | US | disclosed |